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Abstract
Despite growing awareness of the importance of controlling neglected tropical diseases as a contribution to
poverty alleviation and achieving the Millennium Development Goals, there is a need to up-scale programmes to
achieve wider public health benefits. This implementation deficit is attributable to several factors but one often
overlooked is the specific difficulty in tackling diseases that involve both people and animals - the zoonoses. A
Disease Reference Group on Zoonoses and Marginalised Infectious Diseases (DRG6) was convened by the Special
Programme for Research and Training in Tropical Diseases (TDR), a programme executed by the World Health
Organization and co-sponsored by UNICEF, UNDP, the World Bank and WHO. The key considerations included:
(a) the general lack of reliable quantitative data on their public health burden; (b) the need to evaluate livestock
production losses and their additional impacts on health and poverty; (c) the relevance of cross-sectoral issues
essential to designing and implementing public health interventions for zoonotic diseases; and (d) identifying
priority areas for research and interventions to harness resources most effectively. Beyond disease specific research
issues, a set of common macro-priorities and interventions were identified which, if implemented through a more
integrated approach by countries, would have a significant impact on human health of the most marginalised
populations characteristically dependent on livestock.
Introduction
Infectious diseases disproportionately affect poor and
marginalised populations which are subjected to a cycle
of ill-health and poverty. With 60% of human infectious
diseases caused by zoonotic pathogens [1] effective pub-
lic health policy must recognise the importance of inter-
actions between humans and animals [2]. The control of
neglected tropical diseases (NTDs) for poverty allevia-
tion has become an increasing priority [3,4], but ende-
mic zoonotic diseases are still largely ignored by public
health and veterinary services, despite causing a substan-
tial health burden [2,5]. In contrast, for zoonotic dis-
eases with pandemic potential, such as avian or swine
influenza and SARS, the international community has
responded vigorously with committed resources,
reflecting concerns of potential consequences for
higher-income countries.
Many endemic zoonoses have a dual impact on
human health and livestock production. Human popula-
tions dependent on livestock are not only most at direct
risk from zoonotic disease but are most vulnerable to
the indirect impacts on health of reduced production on
livelihoods and food security, which exacerbates the
poverty cycle. It is estimated that over 600 million peo-
ple globally are livestock-dependent, and represent up to
70% of the population in the most marginal areas [6].
These communities are typically isolated from political
processes, communication, education and health care,
due to geographic, economic and socio-cultural factors,
which exacerbate problems of awareness and health-care
delivery.
Effective surveillance and control of zoonotic diseases
usually requires multisectoral collaboration involving the
human health, veterinary, agricultural, educational,
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wildlife and environment and sanitation sectors. It
remains a considerable challenge to coordinate these
different interests, and to achieve collaboration in poli-
cies, priorities, resourcing and communication at the
national and international levels.
Over the last decade significant work on zoonoses has
been undertaken; as a result policy has been articulated
on prevention and control of individual neglected zoo-
notic diseases as a generic concept by WHO and part-
ners at three meetings convened since 2005 [2].
In 2009 WHO UNDP World Bank Special Programme
as part of its stewardship function established a Disease
Reference Group to address with stakeholders’ priority
research issues for Zoonotic Diseases and other margin-
alized infections of poverty (Figure 1). This paper sum-
marises the major findings of DRG6.
Burden of disease
There are four reasons why zoonotic diseases have been
even more neglected than other neglected tropical dis-
eases. Firstly, there is a lack of reliable qualitative and
quantitative data on disease burden in endemic coun-
tries. This must go beyond the traditional disability-
adjusted life year (DALY) assessment to measure and
incorporate monetary and health burdens resulting from
production losses due to disease in animals [5].
Secondly, clinicians and policy makers often have little
knowledge of zoonotic causes of human disease [7] that
can be confused with more widely recognized causes of
common syndromes including febrile illness, or respiratory
or diarrhoeal diseases. Zoonoses presenting as non-specific
febrile illness, for example brucellosis, [8] leptospirosis, [9]
rickettsiosis and Q-fever, [10] are often misdiagnosed as
malaria [11,12]. There is also surprisingly little awareness
that long-term sequelae of zoonoses include cancer (food
borne trematodiases) or neurological disorders
(neurocysticercosis).
Thirdly, the diagnosis of many endemic zoonoses
requires capacities that may only be available in referral
hospitals and reference laboratories, if at all [13]. For
zoonotic schistosomiasis, neurocysticercosis, echinococ-
cosis, opisthorchiasis and clonorchiasis, useful diagnostic
imaging techniques are either unavailable or too expen-
sive; similarly, early diagnosis of many bacterial zoo-
noses depends on sophisticated microbiological or
molecular diagnostic methods typically not available to
those at greatest risk.
Fourthly, data collection systems for zoonotic diseases
are often fragmentary, collected independently by the
public health, veterinary or wildlife sectors and recorded
and reported separately, if they are recorded at all, result-
ing in a failure to identify disease outbreaks. They often
occur in environments beyond the reach of formal health
facilities, education systems and livestock services.
Hence, reporting and certification of deaths, a prerequi-
site for accurate disease burden estimates, often do not
exist, contributing to limited awareness and lack of inter-
est and political will to study and control these diseases.
1. Helminth Infections 
- Taeniasis/Cysticercosis 
- Echinococcosis 
- Food-borne Trematodiases 
- Zoonotic schistosomiasis 
2. Protozoan Infections 
- Cryptosporidiosis 
- Toxoplasmosis 
3. Viral infections 
- Rabies 
4. Bacterial Infections 
- Brucellosis 
- Certain enteric bacterial pathogens 
- Bovine Tuberculosis 
- Anthrax 
Figure 1 DRG6 targeted diseases.
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Standardised measures of public health burden, such
as the DALY, are only currently available for some of
the endemic zoonoses, such as cysticercosis, [14] echi-
nococcosis, [15] human African trypanosomiasis [16]
and rabies [17]. Such data have contributed to policy
change but information on chronic impacts and nonspe-
cific sequelae of untreated zoonoses remains inadequate.
A new metric that incorporates social and economic
outcomes is needed to assess the societal impact of zoo-
notic diseases, and provide the evidence base for objec-
tive decision-making and priority-setting.
Intervention and control of endemic zoonotic diseases
Community-led approaches that empower families and
communities to assume responsibility for aspects of dis-
ease control can result in feasible and cost-effective stra-
tegies to control and, in some cases, eliminate endemic
zoonoses. Experience from other neglected disease pro-
grammes demonstrates the success of these approaches.
For example, the African Program for Onchocerciasis
Control (APOC), directly involves communities in deci-
sion-making, implementation and monitoring of mass
drug administration programmes [18]. Community-led
Total Sanitation (CLTS) is another innovative strategy
for mobilising communities to completely eliminate
open defecation, with sustainable impacts on enteric dis-
eases [19]. Empowering marginalised communities
through community-directed interventions offers great
promise for tackling endemic zoonoses, and should be
encouraged and supported by local and international
technical and financial resources.
Despite these successes, an intervention vacuum still
exists for many zoonoses - even when the outcome and
cost-effectiveness of interventions are known - because
of entrenched perceptions of health impacts and priori-
ties. Local neglect is sometimes exacerbated by interna-
tional disregard, with international priorities focusing on
diseases that pose an emerging global threat, such as
influenza A H5N1, but are of limited importance to
impoverished communities in comparison to endemic
zoonoses. Despite the promise of the Alma Ata Declara-
tion [20] to attain ‘health for all’ by the year 2000, mar-
ginalised communities still suffer from poor access to
health technologies and services, which continues to
undermine all disease control efforts.
“One Health”
The ‘One Health’ philosophy, to forge inclusive colla-
borations between human and animal health profes-
sionals, and related environment and agricultural
disciplines, currently dominates much of the discussion
of zoonotic diseases. While the concept in theory has
been widely embraced progress in practice to ensure
genuine integration lags behind, not only across
academic disciplines, but also with respect to integration
of research with policy. Too often research questions
are formulated without input from policy-makers, when
effective ‘buy-in’ could be achieved by integration and
iterative engagement throughout the research develop-
ment cycle [21-23].
A clear advantage of One Health is that interventions
in animal populations can result in public health and
societal benefits more cost-effectively than just interven-
tions in humans. For example, although human rabies
can be prevented through timely post-exposure prophy-
laxis, the high cost of human vaccination places a signifi-
cant burden on health budgets, in contrast to mass
vaccination of domestic dog reservoirs. Similarly, a com-
prehensive control strategy in China based on interven-
tions to reduce the rate of transmission of Schistosoma
japonicum infection from bovines and humans to snails
has been highly effective, [24] and has now been adopted
by the Chinese government as the national strategy for
the control of schistosomiasis. In Uganda, sleeping sick-
ness caused by Trypanosoma rhodesiense is being con-
trolled by the mass chemotherapy treatment of the cattle
reservoir and insecticidal treatment to control tsetse
populations which also reduces tick populations [5,16].
Integrated, trans-disciplinary approaches envisioned
under One Health are more likely to be adopted when
they provide added value. Many opportunities exist for
adding value through shared resources and expertise,
for example, in zoonotic disease surveillance. Invest-
ments to enhance laboratory capacity to diagnose
avian influenza provided a useful opportunity to
enhance the surveillance of other zoonotic diseases but
there are few examples of this for endemic zoonoses.
The widespread perception that testing human and
animal samples must be conducted in separate labora-
tory facilities, for which there is little rationale,
increases the cost for diagnostic facilities, and is a
major barrier to integration of disease surveillance
efforts between different Ministries.
Whereas One Health aims to expand our thinking
beyond the confines of disciplinary silos, the way for-
ward will not necessarily be straightforward. Tradi-
tional roles and responsibilities may need to be
relinquished while financial control is shared or ceded
entirely to another sector. But, potential health gains
for the most impoverished surely make these changes
worth pressing for.
Macro research priorities and recommendations
to policy makers
DRG6 identified a set of macro-priorities for facilitating
interactions between applied researchers to promote
necessary intervention research on zoonotic diseases of
marginalised populations (Figure 2).
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Investments in disease burden assessments for zoono-
tic diseases are essential to provide an advocacy base to
highlight their importance. A prerequisite is country
prioritisation and commitment from different sectors,
including finance, national research institutions, and
political commitment to stable policy supplemented by
long term international support. This will allow develop-
ment of national guidelines that establish and sustain
veterinary public health units, and clarify their role in
tandem with the human health system. These will
improve public health care for, and actually beyond, the
neglected zoonotic diseases.
1. There is a need to develop a comprehensive methodology for calculating the societal 
burden of disease attributable to zoonoses recognising that a high proportion of the 
population of rural (and often urban) populations in least developed countries depends on 
livestock. 
2. More studies are required to generate data on the costs, cost-benefits and cost 
effectiveness of interventions for endemic zoonoses. Such studies should also incorporate 
the economic effect of animal disease as an indirect contributor to poverty through the 
impact on nutrition, loss of meat and milk products and livestock as a capital asset. 
3. There is a need for operational and systems research to identify reasons for the limited 
communication and interaction between the key sectors - health, agriculture, livestock - 
particularly in countries where a large proportion of the population is dependent on 
livestock. 
4. There is a need to evaluate effective community-based approaches and interventions for 
zoonotic disease, drawing on the experience and success of initiatives for water and 
sanitation improvements, mass drug delivery and community-based health care. 
5. Experiences from separate initiatives in different geographic and epidemiological settings 
need to be evaluated to ensure that such experiences are amplified and synergised, with 
potential for integration between programmes. 
6. Investing in systems for collection of reliable data on disease/infection incidence and 
prevalence from both veterinary and medical sectors is recognised as a priority, both for 
measurement of disease burden and for evaluation of control measures. 
7. Investment in endemic zoonoses in least-developed countries would provide multiple 
benefits, not only improving health and livelihoods of marginalized communities, but also 
reducing threats and enhancing response capacity for emerging zoonoses that pose a threat 
to the global community. 
8. Effective lessons are often best learned by implementation of strategies (such as the 
onchocerciasis control program), with research to evaluate factors leading to success 
measured by effectiveness and cost-effectiveness embedded within programme 
implementation. 
9. As endemic zoonoses disproportionately affect impoverished and marginalised 
populations, investments need to be specifically targeted to overcome barriers to health 
care in these communities, including isolation, population movement or migration, social 
or political unrest, and conflict. 
Figure 2 Macro research priorities identified by DRG6.
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